Lucid Group, Inc. vs Nike, Inc. — Stock Comparison
Q·Score Breakdown
4.2
Underperform
Overall
6.7
Hold
Quality
Health
Growth
Valuation
Sentiment
LCID
Analysts see 111% upside to $12.77 consensus target.
⚠ currently unprofitable (-199% margin).
NKE
Consistently beats earnings estimates (4/4 quarters).
⚠ earnings contracting 35% year-over-year.
Analyst Consensus
HOLD
Target $12.77 (+110.9%)
11 analysts
HOLD
Target $61.68 (+39.6%)
33 analysts
Fundamentals
LCID
NKE
—
Trailing P/E
29.1×
-1.4×
Forward P/E
23.9×
-199.3%
Profit Margin
4.8%
-92.8%
Gross Margin
40.9%
-66.0%
ROE
16.0%
122.9%
Revenue Growth
0.1%
—
Earnings Growth
-34.8%
1.16
Beta
1.32
—
Price / Book
—
$2.2B
Market Cap
$65.4B
$6 – $34
52-Week Range
$42 – $80
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.